New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

NEXT STORY
Amolyt Pharma to Host Key Opinion Leader Webinar and Discuss Results of Phase I Clinical Trial of AZP-3601 on Friday, October 1st at 10:00am ET
PREV STORY
A statement from AK Consulting and Trans on The COVID-19 Lab Leak – Hypothesis: A Reasonable Suspicion or Conspiracy Theory?
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech’s MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific Sessions

AUSTIN, Texas, Nov. 03, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

author_avatar
NASDAQ Market News

ContraFect Announces Third Quarter 2017 Financial Results

YONKERS, N.Y., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

author_avatar
NASDAQ Market News

Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association

NEWTOWN, Pa., June 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

author_avatar
NASDAQ Market News